Table 3

Patients’ profiles and responses to DC vaccination

	HLA-A24	MAGE-3	Sites of tumors	No. of DC vaccinations	Clinical response	Previous treatment	Survival^a
			Right inguinal LN^b			Radical cystectomy
F.Y.	+	+	Para-aorta LN	6	Complete response^c	Chemotherapy	2^d
75 yr F			Right external iliac LN			Radiation
G.K. 65 yr M	+	+	Iliac LN Para-aorta LN Liver Brain^e	18	Partial response of para-aorta LN and complete response of liver metastasis overall progression	Radical cystectomy Chemotherapy Radiation	8
N.H. 64 yr M	+	+	Bilateral inguinal LN Perineum	6	Partial response	TURBT Chemotherapy Radiation	5
N.T.	+	+	Local recurrence	6	Progressive disease	Radical cystectomy	2
56 yr M			Pleural dissemination			Chemotherapy
						Radiation

^a Survival is defined as months to death after the DC vaccination.
^b LN, lymph node.
^c Determined by autopsy.
^d Death attributable to perforation of small intestine.
^e Solitary brain metastasis developed 6 months after the DC vaccination and was surgically removed.